Dados B3 › BAUH4 × JBSS3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BAUH4 | JBSS3 | year |
|---|---|---|---|
| ROE | 17.0%! | 24.8% | 2025 |
| ROIC | 23.3% | 14.4% | 2025 |
| ROA | 11.4% | 5.0% | 2025 |
| Gross margin | 24.9% | 13.1% | 2025 |
| EBIT margin | 8.4% | 4.9% | 2025 |
| Net margin | 8.0% | 2.6% | 2025 |
| Net debt/EBITDA | -2.42x | 2.49x | 2025 |
| Current ratio | 1.80x | 1.60x | 2025 |
| Revenue growth (1y) | 14.7% | 15.3% | 2025 |
| Revenue growth (5y CAGR) | 8.2% | 12.2% | 2025 |
| Piotroski F-Score | 6/9 | 7/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BAUH4 | JBSS3 | year |
|---|---|---|---|
| P/E | 21.91x | 9.40x | 2025 × 2024 |
| P/B | 3.49x | 2.02x | 2025 × 2024 |
| EV/EBITDA | 14.51x | 4.90x | 2025 × 2024 |
| FCF yield | 8.7% | 17.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:35 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it